HEADER TRANSFERASE/TRANSFERASE INHIBITOR 20-MAR-17 5V79 TITLE E. COLI DIHYDROPTEROATE SYNTHASE COMPLEXED WITH AN 8-MERCAPTOGUANINE TITLE 2 DERIVATIVE: 2-((2-AMINO-9-METHYL-6-OXO-6,9-DIHYDRO-1H-PURIN-8-YL) TITLE 3 THIO)-N-PHENYLACETAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROPTEROATE SYNTHASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DHPS,DIHYDROPTEROATE PYROPHOSPHORYLASE; COMPND 5 EC: 2.5.1.15; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI O6:H1 (STRAIN CFT073 / ATCC SOURCE 3 700928 / UPEC); SOURCE 4 ORGANISM_TAXID: 199310; SOURCE 5 STRAIN: CFT073 / ATCC 700928 / UPEC; SOURCE 6 GENE: FOLP, C3933; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS DHPS, COMPLEX, PTERIN SITE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.L.DENNIS,T.S.PEAT,J.D.SWARBRICK REVDAT 3 04-OCT-23 5V79 1 REMARK REVDAT 2 14-FEB-18 5V79 1 JRNL REVDAT 1 06-DEC-17 5V79 0 JRNL AUTH M.L.DENNIS,M.D.LEE,J.R.HARJANI,M.AHMED,A.J.DEBONO, JRNL AUTH 2 N.P.PITCHER,Z.C.WANG,S.CHHABRA,N.BARLOW,R.RAHMANI,B.CLEARY, JRNL AUTH 3 O.DOLEZAL,M.HATTARKI,L.AURELIO,J.SHONBERG,B.GRAHAM,T.S.PEAT, JRNL AUTH 4 J.B.BAELL,J.D.SWARBRICK JRNL TITL 8-MERCAPTOGUANINE DERIVATIVES AS INHIBITORS OF JRNL TITL 2 DIHYDROPTEROATE SYNTHASE. JRNL REF CHEMISTRY V. 24 1922 2018 JRNL REFN ISSN 1521-3765 JRNL PMID 29171692 JRNL DOI 10.1002/CHEM.201704730 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 28201 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1465 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2124 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.33 REMARK 3 BIN R VALUE (WORKING SET) : 0.2680 REMARK 3 BIN FREE R VALUE SET COUNT : 100 REMARK 3 BIN FREE R VALUE : 0.3160 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3983 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 117 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.67000 REMARK 3 B22 (A**2) : 0.23000 REMARK 3 B33 (A**2) : -2.41000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.58000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.271 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.205 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4101 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4033 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5544 ; 1.411 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9261 ; 3.724 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 520 ; 5.512 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 168 ;38.827 ;24.524 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 714 ;13.148 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;13.006 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 643 ; 0.076 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4678 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 890 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2095 ; 2.196 ; 3.837 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2094 ; 2.190 ; 3.835 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2610 ; 3.589 ; 5.732 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2611 ; 3.589 ; 5.734 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2006 ; 2.388 ; 4.136 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2001 ; 2.388 ; 4.137 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2929 ; 3.981 ; 6.081 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4472 ; 5.752 ;29.700 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4473 ; 5.751 ;29.699 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5V79 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1000226994. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29678 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 46.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.19000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 7.32 REMARK 200 R MERGE FOR SHELL (I) : 1.11200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.6.1 REMARK 200 STARTING MODEL: 1AJ2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.248 M MAGNESIUM NITRATE 20.3 %(W/V) REMARK 280 PEG 8000 0.1 M TRIS CHLORIDE, PH 8.8 PROTEIN AT 11.1 MG.ML-1 1:1 REMARK 280 (150:150 NL) RESERVOIR:PROTEIN LIGAND SOAKED INTO CRYSTAL (~4 H, REMARK 280 ~2 MM), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 281K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 47.68200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.81050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 47.68200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 42.81050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -45.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -56.45830 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 157.94244 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 PRO A 25 REMARK 465 ASP A 26 REMARK 465 SER A 27 REMARK 465 PHE A 28 REMARK 465 SER A 29 REMARK 465 ASP A 30 REMARK 465 GLY A 31 REMARK 465 GLY A 32 REMARK 465 THR A 33 REMARK 465 HIS A 34 REMARK 465 GLU A 277 REMARK 465 ASN A 278 REMARK 465 LYS A 279 REMARK 465 ARG A 280 REMARK 465 TYR A 281 REMARK 465 GLU A 282 REMARK 465 GLY B -1 REMARK 465 PRO B 25 REMARK 465 ASP B 26 REMARK 465 SER B 27 REMARK 465 PHE B 28 REMARK 465 SER B 29 REMARK 465 ASP B 30 REMARK 465 GLY B 31 REMARK 465 GLY B 32 REMARK 465 THR B 33 REMARK 465 HIS B 34 REMARK 465 GLY B 143 REMARK 465 ASN B 144 REMARK 465 PRO B 145 REMARK 465 LYS B 146 REMARK 465 THR B 147 REMARK 465 MET B 148 REMARK 465 GLN B 149 REMARK 465 GLU B 150 REMARK 465 ALA B 151 REMARK 465 ASN B 278 REMARK 465 LYS B 279 REMARK 465 ARG B 280 REMARK 465 TYR B 281 REMARK 465 GLU B 282 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 12 41.16 -90.45 REMARK 500 VAL A 23 69.09 -115.20 REMARK 500 ALA A 151 69.06 -153.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8Y4 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8Y4 B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5U0V RELATED DB: PDB REMARK 900 CONTAIN THE SAME PROTEIN IN COMPLEX WITH OTHER PTERIN-SITE REMARK 900 INHIBITORS. REMARK 900 RELATED ID: 5U0Y RELATED DB: PDB REMARK 900 RELATED ID: 5U0X RELATED DB: PDB REMARK 900 RELATED ID: 5U0W RELATED DB: PDB REMARK 900 RELATED ID: 5U10 RELATED DB: PDB REMARK 900 RELATED ID: 5U13 RELATED DB: PDB REMARK 900 RELATED ID: 5U12 RELATED DB: PDB REMARK 900 RELATED ID: 5U11 RELATED DB: PDB REMARK 900 RELATED ID: 5U0Z RELATED DB: PDB REMARK 900 RELATED ID: 5U14 RELATED DB: PDB REMARK 900 RELATED ID: 5V7A RELATED DB: PDB DBREF 5V79 A 1 282 UNP P0AC14 DHPS_ECOL6 1 282 DBREF 5V79 B 1 282 UNP P0AC14 DHPS_ECOL6 1 282 SEQADV 5V79 GLY A -1 UNP P0AC14 EXPRESSION TAG SEQADV 5V79 SER A 0 UNP P0AC14 EXPRESSION TAG SEQADV 5V79 GLY B -1 UNP P0AC14 EXPRESSION TAG SEQADV 5V79 SER B 0 UNP P0AC14 EXPRESSION TAG SEQRES 1 A 284 GLY SER MET LYS LEU PHE ALA GLN GLY THR SER LEU ASP SEQRES 2 A 284 LEU SER HIS PRO HIS VAL MET GLY ILE LEU ASN VAL THR SEQRES 3 A 284 PRO ASP SER PHE SER ASP GLY GLY THR HIS ASN SER LEU SEQRES 4 A 284 ILE ASP ALA VAL LYS HIS ALA ASN LEU MET ILE ASN ALA SEQRES 5 A 284 GLY ALA THR ILE ILE ASP VAL GLY GLY GLU SER THR ARG SEQRES 6 A 284 PRO GLY ALA ALA GLU VAL SER VAL GLU GLU GLU LEU GLN SEQRES 7 A 284 ARG VAL ILE PRO VAL VAL GLU ALA ILE ALA GLN ARG PHE SEQRES 8 A 284 GLU VAL TRP ILE SER VAL ASP THR SER LYS PRO GLU VAL SEQRES 9 A 284 ILE ARG GLU SER ALA LYS VAL GLY ALA HIS ILE ILE ASN SEQRES 10 A 284 ASP ILE ARG SER LEU SER GLU PRO GLY ALA LEU GLU ALA SEQRES 11 A 284 ALA ALA GLU THR GLY LEU PRO VAL CYS LEU MET HIS MET SEQRES 12 A 284 GLN GLY ASN PRO LYS THR MET GLN GLU ALA PRO LYS TYR SEQRES 13 A 284 ASP ASP VAL PHE ALA GLU VAL ASN ARG TYR PHE ILE GLU SEQRES 14 A 284 GLN ILE ALA ARG CYS GLU GLN ALA GLY ILE ALA LYS GLU SEQRES 15 A 284 LYS LEU LEU LEU ASP PRO GLY PHE GLY PHE GLY LYS ASN SEQRES 16 A 284 LEU SER HIS ASN TYR SER LEU LEU ALA ARG LEU ALA GLU SEQRES 17 A 284 PHE HIS HIS PHE ASN LEU PRO LEU LEU VAL GLY MET SER SEQRES 18 A 284 ARG LYS SER MET ILE GLY GLN LEU LEU ASN VAL GLY PRO SEQRES 19 A 284 SER GLU ARG LEU SER GLY SER LEU ALA CYS ALA VAL ILE SEQRES 20 A 284 ALA ALA MET GLN GLY ALA HIS ILE ILE ARG VAL HIS ASP SEQRES 21 A 284 VAL LYS GLU THR VAL GLU ALA MET ARG VAL VAL GLU ALA SEQRES 22 A 284 THR LEU SER ALA LYS GLU ASN LYS ARG TYR GLU SEQRES 1 B 284 GLY SER MET LYS LEU PHE ALA GLN GLY THR SER LEU ASP SEQRES 2 B 284 LEU SER HIS PRO HIS VAL MET GLY ILE LEU ASN VAL THR SEQRES 3 B 284 PRO ASP SER PHE SER ASP GLY GLY THR HIS ASN SER LEU SEQRES 4 B 284 ILE ASP ALA VAL LYS HIS ALA ASN LEU MET ILE ASN ALA SEQRES 5 B 284 GLY ALA THR ILE ILE ASP VAL GLY GLY GLU SER THR ARG SEQRES 6 B 284 PRO GLY ALA ALA GLU VAL SER VAL GLU GLU GLU LEU GLN SEQRES 7 B 284 ARG VAL ILE PRO VAL VAL GLU ALA ILE ALA GLN ARG PHE SEQRES 8 B 284 GLU VAL TRP ILE SER VAL ASP THR SER LYS PRO GLU VAL SEQRES 9 B 284 ILE ARG GLU SER ALA LYS VAL GLY ALA HIS ILE ILE ASN SEQRES 10 B 284 ASP ILE ARG SER LEU SER GLU PRO GLY ALA LEU GLU ALA SEQRES 11 B 284 ALA ALA GLU THR GLY LEU PRO VAL CYS LEU MET HIS MET SEQRES 12 B 284 GLN GLY ASN PRO LYS THR MET GLN GLU ALA PRO LYS TYR SEQRES 13 B 284 ASP ASP VAL PHE ALA GLU VAL ASN ARG TYR PHE ILE GLU SEQRES 14 B 284 GLN ILE ALA ARG CYS GLU GLN ALA GLY ILE ALA LYS GLU SEQRES 15 B 284 LYS LEU LEU LEU ASP PRO GLY PHE GLY PHE GLY LYS ASN SEQRES 16 B 284 LEU SER HIS ASN TYR SER LEU LEU ALA ARG LEU ALA GLU SEQRES 17 B 284 PHE HIS HIS PHE ASN LEU PRO LEU LEU VAL GLY MET SER SEQRES 18 B 284 ARG LYS SER MET ILE GLY GLN LEU LEU ASN VAL GLY PRO SEQRES 19 B 284 SER GLU ARG LEU SER GLY SER LEU ALA CYS ALA VAL ILE SEQRES 20 B 284 ALA ALA MET GLN GLY ALA HIS ILE ILE ARG VAL HIS ASP SEQRES 21 B 284 VAL LYS GLU THR VAL GLU ALA MET ARG VAL VAL GLU ALA SEQRES 22 B 284 THR LEU SER ALA LYS GLU ASN LYS ARG TYR GLU HET 8Y4 A 301 23 HET NO3 A 302 4 HET NO3 A 303 4 HET 8Y4 B 301 23 HETNAM 8Y4 2-[(2-AMINO-9-METHYL-6-OXO-6,9-DIHYDRO-1H-PURIN-8-YL) HETNAM 2 8Y4 SULFANYL]-N-PHENYLACETAMIDE HETNAM NO3 NITRATE ION FORMUL 3 8Y4 2(C14 H14 N6 O2 S) FORMUL 4 NO3 2(N O3 1-) FORMUL 7 HOH *117(H2 O) HELIX 1 AA1 SER A 36 ALA A 50 1 15 HELIX 2 AA2 SER A 70 PHE A 89 1 20 HELIX 3 AA3 LYS A 99 VAL A 109 1 11 HELIX 4 AA4 GLY A 124 GLY A 133 1 10 HELIX 5 AA5 ASP A 156 ALA A 175 1 20 HELIX 6 AA6 ALA A 178 GLU A 180 5 3 HELIX 7 AA7 ASN A 193 ARG A 203 1 11 HELIX 8 AA8 LEU A 204 ASN A 211 5 8 HELIX 9 AA9 LYS A 221 ASN A 229 1 9 HELIX 10 AB1 GLY A 231 GLU A 234 5 4 HELIX 11 AB2 ARG A 235 GLN A 249 1 15 HELIX 12 AB3 ASP A 258 LYS A 276 1 19 HELIX 13 AB4 SER B 36 ALA B 50 1 15 HELIX 14 AB5 SER B 70 PHE B 89 1 20 HELIX 15 AB6 LYS B 99 VAL B 109 1 11 HELIX 16 AB7 GLY B 124 GLY B 133 1 10 HELIX 17 AB8 ASP B 156 ALA B 175 1 20 HELIX 18 AB9 ALA B 178 GLU B 180 5 3 HELIX 19 AC1 ASN B 193 LEU B 204 1 12 HELIX 20 AC2 ALA B 205 ASN B 211 5 7 HELIX 21 AC3 LYS B 221 ASN B 229 1 9 HELIX 22 AC4 GLY B 231 GLU B 234 5 4 HELIX 23 AC5 ARG B 235 GLN B 249 1 15 HELIX 24 AC6 ASP B 258 LYS B 276 1 19 SHEET 1 AA1 2 LYS A 2 ALA A 5 0 SHEET 2 AA1 2 THR A 8 ASP A 11 -1 O THR A 8 N ALA A 5 SHEET 1 AA2 8 LEU A 182 ASP A 185 0 SHEET 2 AA2 8 VAL A 136 MET A 139 1 N LEU A 138 O LEU A 183 SHEET 3 AA2 8 ILE A 113 ASP A 116 1 N ILE A 114 O CYS A 137 SHEET 4 AA2 8 TRP A 92 ASP A 96 1 N VAL A 95 O ASN A 115 SHEET 5 AA2 8 ILE A 54 GLY A 58 1 N ILE A 55 O SER A 94 SHEET 6 AA2 8 HIS A 16 ASN A 22 1 N GLY A 19 O ASP A 56 SHEET 7 AA2 8 ILE A 253 VAL A 256 1 O ILE A 254 N MET A 18 SHEET 8 AA2 8 LEU A 215 GLY A 217 1 N VAL A 216 O ARG A 255 SHEET 1 AA3 2 LYS B 2 ALA B 5 0 SHEET 2 AA3 2 THR B 8 ASP B 11 -1 O LEU B 10 N LEU B 3 SHEET 1 AA4 8 LEU B 182 ASP B 185 0 SHEET 2 AA4 8 VAL B 136 MET B 139 1 N LEU B 138 O LEU B 183 SHEET 3 AA4 8 ILE B 113 ASP B 116 1 N ILE B 114 O CYS B 137 SHEET 4 AA4 8 TRP B 92 ASP B 96 1 N VAL B 95 O ILE B 113 SHEET 5 AA4 8 ILE B 54 GLY B 58 1 N VAL B 57 O ASP B 96 SHEET 6 AA4 8 HIS B 16 ASN B 22 1 N LEU B 21 O ASP B 56 SHEET 7 AA4 8 ILE B 253 VAL B 256 1 O VAL B 256 N MET B 18 SHEET 8 AA4 8 LEU B 215 GLY B 217 1 N VAL B 216 O ARG B 255 SITE 1 AC1 14 THR A 62 ASP A 96 ASN A 115 MET A 139 SITE 2 AC1 14 ASP A 185 PHE A 190 LEU A 215 GLY A 217 SITE 3 AC1 14 ARG A 220 LYS A 221 ARG A 255 HIS A 257 SITE 4 AC1 14 HOH A 415 HOH A 419 SITE 1 AC2 8 VAL A 230 GLY A 231 PRO A 232 ARG A 235 SITE 2 AC2 8 ILE B 48 PHE B 89 GLU B 90 VAL B 91 SITE 1 AC3 10 GLN A 149 GLY A 189 LYS A 192 ASN A 193 SITE 2 AC3 10 LEU A 194 ASN A 197 MET A 223 GLN A 226 SITE 3 AC3 10 HOH A 443 HOH A 457 SITE 1 AC4 12 ASP B 96 ASN B 115 ASP B 185 PHE B 190 SITE 2 AC4 12 LEU B 215 GLY B 217 ARG B 220 LYS B 221 SITE 3 AC4 12 ARG B 255 HIS B 257 HOH B 402 HOH B 406 CRYST1 95.364 85.621 83.865 90.00 109.67 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010486 0.000000 0.003748 0.00000 SCALE2 0.000000 0.011679 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012663 0.00000